Real-world first-line serplulimab-based immunochemotherapy for extensive-stage small cell lung cancer: The multicenter ASTRUM-005R study.

被引：0
|
作者：
Wu, Lin
Hu, ChengPing
Su, Wenzhong
Yu, Yan
Hong, Wei
Liu, Zhigang
Su, Haichuan
Liu, Zhentian
Wang, Caixia
Pu, Qing
Guo, Hui, Sr.
Min, Xuhong
Chen, Yifei
机构：
[1] Cent South Univ, Hunan Canc Hosp, Affiliated Canc Hosp, Dept Thorac Med Oncol,Xiangya Sch Med, Changsha, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Dept Resp & Crit Care Med, Changsha, Hunan, Peoples R China
[3] Shanxi Med Univ, Shanxi Canc Hosp, Canc Hosp, Shanxi Canc Inst,Affiliated Hosp,Shanxi Hosp,Chin, Taiyuan, Peoples R China
[4] Harbin Med Univ, Canc Hosp, Harbin, Peoples R China
[5] Univ Chinese Acad Sci, Canc Hosp, Dept Chest Oncol, Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
[6] Southern Med Univ, Affiliated Hosp 10, Ctr Canc, Dongguan Peoples Hosp, Dongguan, Peoples R China
[7] Air Force Med Univ, Dept Oncol Tangdu Hosp, Xian, Shaanxi, Peoples R China
[8] Jiangxi Canc Hosp, Dept Chest Oncol, Nanchang, Jiangxi, Peoples R China
[9] Shandong First Med Univ, Chemotherapy Dept, Oncol Ctr, Shandong Prov Hosp, Jinan, Peoples R China
[10] Guangxi Med Univ, Dept Oncol, Affiliated Hosp 1, Nanning, Peoples R China
[11] Xi An Jiao Tong Univ, Affiliated Hosp 2, Xian, Peoples R China
[12] Anhui Chest Hosp, Oncol Radiotherapy Dept, Hefei, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20106
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Clinicopathological Features and First-Line Treatment Outcomes of Geriatric Patients With Extensive-Stage Small Cell Lung Cancer: A Multicenter Study
    Ilhan, Aysegul
    Gurler, Fatih
    Yilmaz, Funda
    Seyran, Erdogan
    Bastug, Vural
    Gorgulu, Bugra
    Eraslan, Emrah
    Yildirim, Ozgen Ahmet
    Yazici, Ozan
    Oksuzoglu, Omur Berna Cakmak
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (03)
  • [22] French real world study on patient characteristics and treatment strategies in first-line of extensive-stage small cell lung cancer (ES SCLC)
    Debieuvre, D.
    Dayen, C.
    Dixmier, A.
    Gally, S.
    Pau, D.
    Greenwood, W.
    Falchero, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S1038 - S1038
  • [23] Real-World Efficacy and Safety of Thoracic Radiotherapy after First-Line Chemo-Immunotherapy in Extensive-Stage Small-Cell Lung Cancer
    Xie, Zhaoliang
    Liu, Jingru
    Wu, Min
    Wang, Xiaohan
    Lu, Yuhan
    Han, Chunyan
    Cong, Lei
    Li, Jisheng
    Meng, Xue
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (11)
  • [24] Comparison of Real-world Efficacy and Safety of Atezolizumab and Durvalumab in Combination With Chemotherapy for First-line Treatment of Extensive-stage Small-cell Lung Cancer
    Igata, Fumiyasu
    Inoue, Hiroyuki
    Ikeda, Takato
    Nakao, Akira
    Ebi, Noriyuki
    Fujita, Masaki
    ANTICANCER RESEARCH, 2024, 44 (07) : 3175 - 3183
  • [25] Atezolizumab plus chemotherapy followed by atezolizumab plus anlotinib in the first-line treatment for extensive-stage small cell lung cancer: A multicenter, single-arm, prospective real-world study
    Pan, Y.
    Qian, X.
    Zhou, H.
    Jin, W.
    Chen, J.
    Wang, Y.
    Zhang, Z.
    Liu, H.
    Jin, Y.
    Jiang, F.
    Liu, H.
    ANNALS OF ONCOLOGY, 2024, 35 : S1071 - S1071
  • [26] First-line pembrolizumab for lung cancer in a Spanish real-world study.
    Burgos, Amparo
    Calleja, Teresa
    Ibanez, Cristina
    Maria Valencia, Carmen
    Orallo, Claudia
    Carlos Titos, Jose
    Conde, David
    Diaz, Sacramento
    Matilla, Belen
    Lizeaga, Garbine
    Sanchez, Carmen
    Marin Pozo, Juan Francisco
    Jimenez, Silvia
    Jimenez, Inmaculada
    Diez, Raul
    Garrido, Margarita
    Larrosa, Maria
    Jose Martinez, Maria
    Moreno, Estela
    Garcia Campelo, Rosario
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [27] First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
    Horn, L.
    Mansfield, A. S.
    Szczesna, A.
    Havel, L.
    Krzakowski, M.
    Hochmair, M. J.
    Huemer, F.
    Losonczy, G.
    Johnson, M. L.
    Nishio, M.
    Reck, M.
    Mok, T.
    Lam, S.
    Shames, D. S.
    Liu, J.
    Ding, B.
    Lopez-Chavez, A.
    Kabbinavar, F.
    Lin, W.
    Sandler, A.
    Liu, S. V.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (23): : 2220 - 2229
  • [28] Efficacy and safety of integrating consolidative thoracic radiotherapy with immunochemotherapy in extensive-stage small cell lung cancer: a real-world retrospective analysis
    Zhang, Qi
    Wang, Qian
    Wang, Mengsen
    Liu, Xiaomeng
    Han, Dan
    Sun, Hongfu
    Zhao, Chengwei
    Liu, Chengxin
    JOURNAL OF THORACIC DISEASE, 2025, 17 (02)
  • [29] A real-world study of anlotinib in combination with PD-L1 inhibitors plus chemotherapy as first-line therapy for extensive-stage small cell lung cancer.
    Chen, Size
    Lin, Yiguang
    Song, Minghan
    Dong, Jiayi
    Lijuan, Shao
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [30] Phase I study of paclitaxel and topotecan for the first-line treatment of extensive-stage small cell lung cancer
    West, W
    Birch, R
    Schnell, F
    Hainsworth, J
    Tongol, J
    Campos, L
    ONCOLOGIST, 2003, 8 (01): : 76 - 82
12345